U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 6266829

Combination Beverage Container and Spittoon

A combination beverage container and spittoon includes a bottom portion including outer wall and a first inner wall defining a spittoon space.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 424/558 - Urogenital system (e.g., kidney, etc.)


Subclass of Class 424 - Drug, bio-affecting and body treating compositions
Definition: Subject matter in which the material is or is derived from
No. of patents: 40
Last issue date: 08/31/2010


NumberTitleIssue Date
7785635Methods of use of probiotic for companion animals
According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Lactobacilli. ...
08/31/2010
7780992Antiviral medicament
There is disclosed a prophylactic and therapeutic antiviral composition and in particular compositions which comprise containing vertebrates kidney as a main component. Use of the composition through parenteral administration for the prevention and treatment of vira...
08/24/2010
7320788Enzyme treatment of foodstuffs for Celiac Sprue
Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten. ...
01/22/2008
7235262Use of bioactive fraction from cow urine distillate (‘’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
The invention relates to a novel pharmaceutical composition comprising an effective amount of bio-active fraction from cow urine distillate as a bioavailability facilitator and pharmaceutically acceptable additives selected from anticancer compounds, antibiotics, dr...
06/26/2007
6896907Use of bioactive fraction from cow urine distillate (‘go-mutra’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
The invention relates to a novel pharmaceutical composition comprising an effective amount of bio-active fraction from cow urine distillate as a bioavailability facilitator and pharmaceutically acceptable additives selected from anticancer compounds, antibiotics, dr...
05/24/2005
6890564Tissue regenerative composition, method of making, and method of use thereof
A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ...
05/10/2005
6887495Tissue regenerative composition, method of making, and method of use thereof
A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ...
05/03/2005
6861074Tissue regenerative composition, method of making, and method of use thereof
A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ...
03/01/2005
6849273Tissue regenerative composition, method of making, and method of use thereof
A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ...
02/01/2005
6783776Tissue regenerative composition, method of making, and method of use thereof
A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ...
08/31/2004
6649160Sertoli cells as transplantation facilitator for cell transplantation
A method of producing a sustained localized immunosuppressive effect in localized tissues is achieved by transplanting Sertoli cells proximate to the tissue....
11/18/2003
6579538Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof
A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate....
06/17/2003
6485723Enhanced submucosal tissue graft constructs
An improved tissue graft construct comprising submucosa of a warm-blooded vertebrate and a preselected group of eukaryotic cells are described. The improved tissue graft constructs can be used in accordance with the present invention to enhance the repair...
11/26/2002
6410059Pharmaceutical composition containing cow urine distillate and an antibiotic
A pharmaceutical composition comprising an antibiotic and cow urine distillate in an amount effective to enhance antimicrobial effect of the antibiotic is disclosed. The antibiotic can be an antifungal agent. The antibiotic can be a quinolone or a fluoroq...
06/25/2002
6054142Biocompatible devices with foam scaffolds
A biocompatible cell device having an internal foam scaffold to provide a growth surface for encapsulated cells which produce a biologically active molecule....
04/25/2000
5928670Method of inhibiting aldose reductase in vivo with intrinsic inhibitors of aldose reductase
An intrinsic aldose reductase inhibitor is isolated and purified from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor may be incorporated into pharmaceutical compositions for the treatment of certain conditions...
07/27/1999
5824493Diagnostic test for interstitial cystitis
A method of diagnosing interstitial cystitits in an individual and a kit for the method, comprising the steps of: obtaining primary cultures of urothelial cells; selecting urothelial cells of basal type and producing secondary cultures; measuring in secon...
10/20/1998
5738878Process for making intrinsic inhibitors of aldose reductase
An intrinsic aldose reductase inhibitor is isolated and purified from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor may be incorporated into pharmaceutical compositions for the treatment of certain conditions...
04/14/1998
5702700Sertoli cells as neurorecovery inducing cells for Parkinson's disease
A method of generating in situ trophic factor production by transplanting Sertoli cells into the central nervous system of a mammal, the cells creating trophic factors in situ....
12/30/1997
5700783Method of treating urinary incontinence
A method for treating urinary incontinence consisting of injecting human fibrin glue at or near the bladder neck until the urethral outflow resistance is restored. Human fibrin glue is the reaction product of human fibrinogen and thrombin in the presence ...
12/23/1997
5695785Kidney extract for treatment of systematic lupus erythematosus
The invention is directed to a method of treating systematic lupus erythematosus (SLE) in animals, including humans, by the oral administration of kidney extracts to decrease anti-DNA antibody production. The method of the invention includes both prophyla...
12/09/1997
5618917Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells
An autocrine crystal adhesion inhibitor called CAI is an anionic, sialic acid-containing glycoprotein secreted by kidney epithelial cells that blocks adhesion of calcium oxalate monohydrate (COM) crystals to the cell surfaces. Persons may be classified ac...
04/08/1997
5560936Intrinsic inhibitors of aldose reductase
An intrinsic aldose reductase inhibitor is isolated and purified from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor may be incorporated into pharmaceutical compositions for the treatment of certain conditions...
10/01/1996
5560935Physiologically active substances extracted from activated tissues
The present invention provides a physiologically active substance which inhibits plasma kallikrein production, improves peripheral blood flow, and exhibits analgesic, antiinflammatory and antiallergic action. The physiologically active substance of the pr...
10/01/1996
5554389Urinary bladder submucosa derived tissue graft
A tissue graft composition comprising bladder submucosal tissue delaminated from abluminal muscle layers and at least the luminal portion of the tunica mucosa of a segment of vertebrate urinary bladder is described. The graft composition can be implanted ...
09/10/1996
5510263Growth of pancreatic islet-like cell clusters
A method for growing endocrine precursor cells in vitro, such as pancreatic islet precursors, by culturing such cells in the presence or absence of cell matrix proteins capable of promoting hemidesmosome formation, such as those produced by the rat bladde...
04/23/1996
5476922Methods and compositions for the preparation and use of autocrine growth factors
Autocrine growth factors and isoforms of those factors have been identified, isolated, purified and manipulated. Nucleic acid segments coding for the factors, and antibodies directed to the factors are also aspects of the present invention. The effect of ...
12/19/1995
5324822Method of isolating a CA 195-like immunoreactive antigen from human amniotic fluid
A method of isolation of a material with similar immunological properties to CA-195 from human amniotic fluid has been disclosed. This material can be substituted for CA-195 in many processes, for example in the preparation of analytical control materials...
06/28/1994
5268175Cosmetic and/or pharmaceutical compositions and methods for their use
Topical cosmetic and pharmaceutical compositions are provided for the external protection of human or animal tissues from contact with heavy metals, and the composition includes a metal sequestering component capable of binding metal ions and a physiologi...
12/07/1993
5198216Performance enhancing compositions of matter, and methods of preparing and utilizing same
A composition for enhancing the performance of animals, such as horses or dogs, is composed of adrenal and pituitary raw tissue concentrates, vitamin C, bioflavonoid complex, pantothenic acid, methionine, choline, vitamin B1, vitamin B2, vitamin B6, niaci...
03/30/1993
5057324Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof
A physiologically active substance is extracted from infected tissues inoculated with a poxvirus. The novel substance of the present invention has inhibitory action against the formation of kallikrein, thus is useful as drugs such as antiinflammatory, ana...
10/15/1991
4985542Kit for the determination and diagnosis of non-goodpasture glomerulonephritis
Purified glomerular proteoglycans are used as a basis for a diagnostic test for glomerulonephritis in humans involving an immunological reaction between the purified proteoglycans and patient area. A new method for purification of glomeruli proteoglycan a...
01/15/1991
4985254Method of treating ischemic diseases
The present invention relates to physiologically active substances extracted from infected tissues inoculated with a poxvirus. The substances of the present invention have excellent actions to improve blood flow and recover functions of diseased tissues, ...
01/15/1991
4963358Agent for inhibiting proliferation of human malignant tumor cells
An agent for inhibiting proliferation of human malignant tumor cells is obtained by culturing the human malignant tumor cells in a medium and removing the malignant tumor cells from the cultured medium....
10/16/1990
4908206Extracts of embryonic organs, process for their preparation and pharmaceutical preparation containing them
From organs of embryonic mammalia a new extract of active ingredients is recovered which extract can be used for controlling a reduced blood flow through periperhic organs and through the brain and which extract can be also used for controlling acne vulga...
03/13/1990
4749522Supercritical fluid extraction of animal derived materials
Supercritical fluids (SCF) are found to be useful in extracting desired materials from animal tissues, cells, and organs. By varying the choice of SCF, experimental conditions, and animal source material, one may obtain lipids, proteins, nucleotides, sacc...
06/07/1988
4507229Tissue protein PP4, a process for isolating it and its use
The protein PP4 which has (a) an electrophoretic mobility in the range between that of 댑 and 댒 globulins; (b) an isoelectric point of 4.85&#b1;0.15; (c) a sedimentation coefficient s20,w0 of 3.3&#...
03/26/1985
4382887Novel glycopeptide and methods of isolating and using the same
A novel glycopeptide is disclosed, which consists of a sugar moiety having a structural formula ##STR1## and a peptide moiety linking to the sugar moiety through N-glycoside bond. The glycopeptide is isolated from organs of normal animals, especially...
05/10/1983
4206201Method for preparing a compound called ARL per se and its use as medicinal
Compound (hereinafter identified as ARL) useful as a vasodilator and antihypertensive agent. The compound is obtainable using rabbit kidney medulla by first incubating same, second, operating on the incubated material and then purifying the operated upon ...
06/03/1980
4083961Plasminogen activator pharmaceutical compositions
The present invention relates to a pharmaceutical composition comprising a plasminogen activator and a polysaccharide sulphate. The invention also covers a process for preparing the pharmaceutical composition and a process for preparing the plasminogen ac...
04/11/1978
 
Sign InRegister
Username  
Password   
forgot password?